Victoria Wirtz

Victoria is a biostatistician with over 28 years of experience in the pharmaceutical industry. She was previously employed at Bristol-Myers Squibb where she was promoted from protocol statistician to the virology lead for the HIV and HBV portfolio where she oversaw all phases of clinical trials. Victoria has led her teams to successful global filings for both adult and pediatric indications while also helping to build a new function within the statistics department, Planning and Execution (P&E). Victoria managed a team of P&E leads overseeing oncology, cardiovascular and virology, working closely with the internal teams and vendors to ensure high quality analyses. As a member of cross-functional teams, she has been part of due diligence for in-licensing assets as well as selecting statistical programming vendors. Victoria earned her M.S. in Biostatistics at the University of Minnesota.